Do older people need to reduce the dose when using Ivosidenib?

Ivosidenib (Ivosidenib) is an oral targeted drug mainly used to treat certain types of acute myeloid leukemia (AML) and other solid tumors with IDH1 gene mutations. Dosage adjustment of the drug is particularly important when using ivonib in elderly patients. Because the physiological functions of the elderly are different from those of young people, especially liver and kidney functions may be reduced, which may affect the metabolism and excretion of drugs, thereby increasing the risk of drug toxicity.

At present, clinical trials and drug instructions do not clearly require the dose reduction of ivonib due to age alone. In most cases, elderly patients are initiated on standard recommended doses, but patients need to be closely monitored for tolerance and adverse effects during treatment. If serious side effects or drug-related toxicity occur, doctors will adjust the dose or temporarily discontinue the drug based on the patient's specific condition. Especially for elderly patients with abnormal liver function or other comorbidities, individualized medication adjustment is more critical.

In addition, elderly patients often have multiple underlying diseases and take more concomitant medications, which also increases the risk of drug interactions. The metabolism of ivosidenib mainly depends on the liver. If concomitant drugs affect liver enzyme activity, the dose of ivosidenib may need to be adjusted. Clinicians should flexibly adjust the dose based on the patient's overall health status, liver and kidney function indicators, and medication response to ensure efficacy while reducing adverse reactions.

In short, when elderly patients are treated with ivonib, although initial dose reduction is not necessarily required, monitoring should be strengthened, with special attention to liver and kidney function and side effects. If intolerance occurs, the dose should be adjusted based on specific clinical manifestations. Individualized treatment strategies are the key to ensuring safe and effective medication for elderly patients. It is recommended that patients undergo treatment and follow-up under the guidance of professional physicians.

Reference link:https://www.tibsovo.com/